CLINICAL RESEARCH: CARDIAC IMAGING
Prognostic Value of Myocardial Viability Detected by Myocardial Contrast Echocardiography Early After Acute Myocardial Infarction
Girish Dwivedi, MD, MRCP, DM,
Rajesh Janardhanan, MD, MRCP,
Sajad A. Hayat, MBChB, MRCP,
John M. Swinburn, MD, MRCP and
Roxy Senior, MD, DM, FRCP, FESC, FACC*
Department of Cardiovascular Medicine, Northwick Park Institute of Medical Research, Northwick Park Hospital, Harrow, Middlesex, United Kingdom.
Manuscript received January 16, 2007;
revised manuscript received March 1, 2007,
accepted March 12, 2007.
* Reprint requests and correspondence: Prof. Roxy Senior, Department of Cardiology, Northwick Park Hospital, Harrow, Middlesex, HA1 3UJ, Hon. Professor, Middlesex University, United Kingdom. (Email: roxysenior{at}cardiac-research.org).
Objectives: This study sought to determine whether residual myocardial viability determined by myocardial contrast echocardiography (MCE) after acute myocardial infarction (AMI) can predict hard cardiac events.
Background: Myocardial viability detected by MCE has been shown to predict recovery of left ventricular (LV) function in patients with AMI. However, to date no study has shown its value in predicting major adverse outcomes in AMI patients after thrombolysis.
Methods: Accordingly, 99 stable patients underwent low-power MCE at 7 ± 2 days after AMI. Contrast defect index (CDI) was obtained by adding contrast scores (1 = homogenous; 2 = reduced; 3 = minimal/absent opacification) in all 16 LV segments divided by 16. At discharge, 65 (68%) patients had either undergone or were scheduled for revascularization independent of the MCE result. The patients were subsequently followed up for cardiac death and nonfatal AMI.
Results: Of the 99 patients, 95 were available for follow-up. Of these, 86 (87%) underwent thrombolysis. During the follow-up time of 46 ± 16 months, there were 15 (16%) events (8 cardiac deaths and 7 nonfatal AMIs). Among the clinical, biochemical, electrocardiographic, echocardiographic, and coronary arteriographic markers of prognosis, the extent of residual myocardial viability was an independent predictor of cardiac death (p = 0.01) and cardiac death or AMI (p = 0.002). A CDI of 1.86 and 1.67 predicted survival and survival or absence of recurrent AMI in 99% and 95% of the patients, respectively.
Conclusions: The extent of residual myocardial viability predicted by MCE is a powerful independent predictor of hard cardiac events in patients after AMI.
|
Abbreviations and Acronyms
| | AMI = acute myocardial infarction | | CAD = coronary artery disease | | CDI = contrast defect index | | DSE = dobutamine stress echocardiography | | LV = left ventricular | | LVEDV = left ventricular end-diastolic volume | | LVEF = left ventricular ejection fraction | | LVESV = left ventricular end-systolic volume | | MCE = myocardial contrast echocardiography |
|
Related Article
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2007 50: A23-A24.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
P. Nihoyannopoulos and F. Pinto
Chapter 12 Ischaemic heart disease
The EAE Textbook of Echocardiography,
March 1, 2011;
1(1):
med-9780199599639-chapter - med-9780199599639-chapter.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Anantharam, R. Janardhanan, S. Hayat, M. Hickman, N. Chahal, P. Bassett, and R. Senior
Coronary flow reserve assessed by myocardial contrast echocardiography predicts mortality in patients with heart failure
Eur Heart J Cardiovasc Imaging,
January 1, 2011;
12(1):
69 - 75.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Nucifora, N. A. Marsan, M. Bertini, V. Delgado, H.-M. J. Siebelink, J. M. van Werkhoven, A. J. Scholte, M. J. Schalij, E. E. van der Wall, E. R. Holman, et al.
Reduced Left Ventricular Torsion Early After Myocardial Infarction Is Related to Left Ventricular Remodeling
Circ Cardiovasc Imaging,
July 1, 2010;
3(4):
433 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Porter and F. Xie
Myocardial Perfusion Imaging With Contrast Ultrasound
J. Am. Coll. Cardiol. Img.,
February 1, 2010;
3(2):
176 - 187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Mollema, V. Delgado, M. Bertini, M. L. Antoni, E. Boersma, E. R. Holman, M. P.M. Stokkel, E. E. van der Wall, M. J. Schalij, and J. J. Bax
Viability Assessment With Global Left Ventricular Longitudinal Strain Predicts Recovery of Left Ventricular Function After Acute Myocardial Infarction
Circ Cardiovasc Imaging,
January 1, 2010;
3(1):
15 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Dwivedi, R. Janardhanan, S. A. Hayat, T. K. Lim, and R. Senior
Improved prediction of outcome by contrast echocardiography determined left ventricular remodelling parameters compared to unenhanced echocardiography in patients following acute myocardial infarction
Eur Heart J Cardiovasc Imaging,
December 1, 2009;
10(8):
933 - 940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S A Mollema, G Nucifora, and J J Bax
Prognostic value of echocardiography after acute myocardial infarction
Heart,
November 1, 2009;
95(21):
1732 - 1745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Niccoli, D. Schiavino, F. Belloni, G. Ferrante, G. La Torre, M. Conte, N. Cosentino, R. A. Montone, V. Sabato, F. Burzotta, et al.
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents
Eur. Heart J.,
June 1, 2009;
30(11):
1340 - 1347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Funaro, G. La Torre, M. Madonna, L. Galiuto, A. Scara, A. Labbadia, E. Canali, A. Mattatelli, F. Fedele, F. Alessandrini, et al.
Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study
Eur. Heart J.,
March 1, 2009;
30(5):
566 - 575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Senior, H. Becher, M. Monaghan, L. Agati, J. Zamorano, J. L. Vanoverschelde, and P. Nihoyannopoulos
Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography
Eur Heart J Cardiovasc Imaging,
March 1, 2009;
10(2):
194 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Dolan, S. S. Gala, S. Dodla, S. S. Abdelmoneim, F. Xie, D. Cloutier, M. Bierig, S. L. Mulvagh, T. R. Porter, and A. J. Labovitz
Safety and Efficacy of Commercially Available Ultrasound Contrast Agents for Rest and Stress Echocardiography: A Multicenter Experience
J. Am. Coll. Cardiol.,
January 6, 2009;
53(1):
32 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kaul
Myocardial Contrast Echocardiography: A 25-Year Retrospective
Circulation,
July 15, 2008;
118(3):
291 - 308.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Hayat and R. Senior
Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time?
Eur. Heart J.,
February 1, 2008;
29(3):
299 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|